{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T20:18:21Z","timestamp":1794341901963,"version":"4.9.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To map current literature and provide an overview of upcoming future diagnostic and prognostic methods for upper tract urothelial carcinoma (UTUC), including translational medical science.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A scoping review approach was applied to search the literature. Based on the published literature, and the experts own experience and opinions consensus was reached through discussions at the meeting Consultation on UTUC II in Stockholm, September 2022.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The gene mutational profile of UTUC correlates with stage, grade, prognosis, and response to different therapeutic strategies. Analysis of pathway proteins downstream of known pathogenic mutations might be an alternative approach.<\/jats:p>\n                <jats:p>Liquid biopsies of cell-free DNA may detect UTUC with a higher sensitivity and specificity than urinary cytology. Extracellular vesicles from tumour cells can be detected in urine and may be used to identify the location of the urothelial carcinoma in the urinary tract. 3D microscopy of UTUC samples may add information in the analysis of tumour stage. Chemokines and chemokine receptors were linked to overall survival and responsiveness to neoadjuvant chemotherapy in muscle-invasive bladder cancer, which is potentially also of interest in UTUC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Current diagnostic methods for UTUC have shortcomings, especially concerning prognostication, which is important for personalized treatment decisions. There are several upcoming methods that may be of interest for UTUC. Most have been studied for urothelial carcinoma of the bladder, and it is important to keep in mind that UTUC is a different entity and not all methods are adaptable or applicable to UTUC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00345-023-04597-4","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T10:03:03Z","timestamp":1695117783000},"page":"3405-3411","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Consultation on UTUC II Stockholm 2022: diagnostic and prognostic methods\u2014what\u2019s around the corner?"],"prefix":"10.1007","volume":"41","author":[{"given":"Alexandra","family":"Grahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylva","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Gabrielsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonna Skov","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Turney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Uhl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tino","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Zieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palle J\u00f6rn Sloth","family":"Osther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9232-363X","authenticated-orcid":false,"given":"Marianne","family":"Brehmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"key":"4597_CR1","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1007\/s00345-020-03576-3","volume":"39","author":"B Almas","year":"2021","unstructured":"Almas B, Halvorsen OJ, Johannesen TB, Beisland C (2021) Higher than expected and significantly increasing incidence of upper tract urothelial carcinoma. A population based study. World J Urol 39:3385\u20133391","journal-title":"World J Urol"},{"issue":"3","key":"4597_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/bju.15389","volume":"128","author":"T van Doeveren","year":"2021","unstructured":"van Doeveren T, van der Mark M, van Leeuwen PJ, Boormans JL, Aben KKH (2021) Rising incidence rates and unaltered survival rates for primary upper urinary tract urothelial carcinoma: a Dutch population-based study from 1993 to 2017. BJU Int 128(3):343\u2013351","journal-title":"BJU Int"},{"issue":"5","key":"4597_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11934-016-0595-1","volume":"17","author":"JD Raman","year":"2016","unstructured":"Raman JD, Jafri SM (2016) Complications following radical nephroureterectomy. Curr Urol Rep 17(5):36","journal-title":"Curr Urol Rep"},{"issue":"2","key":"4597_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/end.2013.0436","volume":"28","author":"J de la Rosette","year":"2014","unstructured":"de la Rosette J, Denstedt J, Geavlete P, Keeley F, Matsuda T, Pearle M et al (2014) The clinical research office of the endourological society ureteroscopy global study: indications, complications, and outcomes in 11,885 patients. J Endourol 28(2):131\u2013139","journal-title":"J Endourol"},{"issue":"11","key":"4597_CR5","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1111\/j.1464-410X.2012.11169.x","volume":"110","author":"ML Cutress","year":"2012","unstructured":"Cutress ML, Stewart GD, Wells-Cole S, Phipps S, Thomas BG, Tolley DA (2012) Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience. BJU Int 110(11):1608\u20131617","journal-title":"BJU Int"},{"issue":"2","key":"4597_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/bju.14053","volume":"121","author":"RQ Guo","year":"2018","unstructured":"Guo RQ, Hong P, Xiong GY, Zhang L, Fang D, Li XS et al (2018) Impact of ureteroscopy before radical nephroureterectomy for upper tract urothelial carcinomas on oncological outcomes: a meta-analysis. BJU Int 121(2):184\u2013193","journal-title":"BJU Int"},{"issue":"18","key":"4597_CR7","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.3390\/jcm10184197","volume":"10","author":"\u0141 Nowak","year":"2021","unstructured":"Nowak \u0141, Krajewski W, Chorbi\u0144ska J, Kie\u0142b P, Sut M, Moschini M et al (2021) The impact of diagnostic ureteroscopy prior to radical nephroureterectomy on oncological outcomes in patients with upper tract urothelial carcinoma: a comprehensive systematic review and meta-analysis. J Clin Med 10(18):4197","journal-title":"J Clin Med"},{"issue":"11","key":"4597_CR8","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/j.1464-410X.2012.11066.x","volume":"110","author":"M Grasso","year":"2012","unstructured":"Grasso M, Fishman AI, Cohen J, Alexander B (2012) Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients. BJU Int 110(11):1618\u20131626","journal-title":"BJU Int"},{"issue":"6","key":"4597_CR9","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1016\/j.juro.2010.02.005","volume":"183","author":"AJ Gadzinski","year":"2010","unstructured":"Gadzinski AJ, Roberts WW, Faerber GJ, Wolf JS Jr (2010) Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. J Urol 183(6):2148\u20132153","journal-title":"J Urol"},{"issue":"1","key":"4597_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/cncr.11446","volume":"98","author":"S Daneshmand","year":"2003","unstructured":"Daneshmand S, Quek ML, Huffman JL (2003) Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience. Cancer 98(1):55\u201360","journal-title":"Cancer"},{"issue":"11","key":"4597_CR11","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00345-019-02732-8","volume":"37","author":"G Fojecki","year":"2019","unstructured":"Fojecki G, Magnusson A, Traxer O, Baard J, Osther PJS, Jaremko G et al (2019) Consultation on UTUC, Stockholm 2018 aspects of diagnosis of upper tract urothelial carcinoma. World J Urol 37(11):2271\u20132278","journal-title":"World J Urol"},{"issue":"11","key":"4597_CR12","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.ejso.2020.06.024","volume":"46","author":"JD Subiela","year":"2020","unstructured":"Subiela JD, Territo A, Mercade A, Balana J, Aumatell J, Calderon J et al (2020) Diagnostic accuracy of ureteroscopic biopsy in predicting stage and grade at final pathology in upper tract urothelial carcinoma: Systematic review and meta-analysis. Eur J Surg Oncol 46(11):1989\u20131997","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"4597_CR13","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/j.1464-410X.2010.09899.x","volume":"108","author":"J Messer","year":"2011","unstructured":"Messer J, Shariat SF, Brien JC, Herman MP, Ng CK, Scherr DS et al (2011) Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int 108(5):701\u2013705","journal-title":"BJU Int"},{"issue":"2","key":"4597_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/21681805.2017.1295102","volume":"51","author":"C Malm","year":"2017","unstructured":"Malm C, Grahn A, Jaremko G, Tribukait B, Brehmer M (2017) Diagnostic accuracy of upper tract urothelial carcinoma: how samples are collected matters. Scand J Urol 51(2):137\u2013145","journal-title":"Scand J Urol"},{"issue":"2","key":"4597_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.urology.2005.03.011","volume":"66","author":"S Holm\u00e4ng","year":"2005","unstructured":"Holm\u00e4ng S, Johansson SL (2005) Urothelial carcinoma of the upper urinary tract: comparison between the WHO\/ISUP 1998 consensus classification and WHO 1999 classification system. Urology 66(2):274\u2013278","journal-title":"Urology"},{"key":"4597_CR16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.euf.2021.03.017","volume":"8","author":"T van der Kwast","year":"2021","unstructured":"van der Kwast T, Liedberg F, Black PC, Kamat A, van Rhijn BWG, Algaba F et al (2021) International society of urological pathology expert opinion on grading of urothelial carcinoma. Eur Urol Focus. 8:438\u2013446","journal-title":"Eur Urol Focus."},{"issue":"2","key":"4597_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.euo.2020.12.002","volume":"4","author":"BWG van Rhijn","year":"2021","unstructured":"van Rhijn BWG, Hentschel AE, Brundl J, Comperat EM, Hernandez V, Capoun O et al (2021) Prognostic Value of the WHO1973 and WHO2004\/2016 classification systems for grade in primary Ta\/T1 Non-muscle-invasive Bladder Cancer: a Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study. Eur Urol Oncol 4(2):182\u2013191","journal-title":"Eur Urol Oncol"},{"key":"4597_CR18","unstructured":"Roupr\u00eat M, Burger M, Comp\u00e9rat E, Gontero P, Liedberg F, Masson-Lecomte A, Mostafid AH, Palou J, van Rhijn BWG, Sylvester R, Patient Advocates: Benedicte Gurses I, Wood R, Guidelines Associates: Capoun O, Cohen D, Dominguez-Escrig JL, Seisen T, Soukup V (2022) EAU Guidelines on Upper Tract Urothelial Carcinoma 2022"},{"issue":"7","key":"4597_CR19","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/jso.25877","volume":"121","author":"G Rosiello","year":"2020","unstructured":"Rosiello G, Palumbo C, Knipper S, Pecoraro A, Luzzago S, Deuker M et al (2020) Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract. J Surg Oncol 121(7):1154\u20131161","journal-title":"J Surg Oncol"},{"issue":"11","key":"4597_CR20","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1007\/s00345-019-02760-4","volume":"37","author":"C Malm","year":"2019","unstructured":"Malm C, Grahn A, Jaremko G, Tribukait B, Brehmer M (2019) Predicting invasiveness and disease-specific survival in upper tract urothelial carcinoma: identifying relevant clinical tumour characteristics. World J Urol 37(11):2335\u20132342","journal-title":"World J Urol"},{"issue":"4","key":"4597_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.eururo.2021.05.004","volume":"80","author":"B Foerster","year":"2021","unstructured":"Foerster B, Abufaraj M, Matin SF, Azizi M, Gupta M, Li WM et al (2021) Pretreatment risk stratification for endoscopic kidney-sparing surgery in upper tract urothelial carcinoma: an international collaborative study. Eur Urol 80(4):507\u2013515","journal-title":"Eur Urol"},{"issue":"3","key":"4597_CR22","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.euf.2021.05.002","volume":"8","author":"S Katayama","year":"2022","unstructured":"Katayama S, Mori K, Schuettfort VM, Pradere B, Mostafaei H, Quhal F et al (2022) Accuracy and clinical utility of a tumor grade- and stage-based predictive model in localized upper tract urothelial carcinoma. Eur Urol Focus 8(3):761\u2013768","journal-title":"Eur Urol Focus"},{"issue":"3","key":"4597_CR23","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD et al (2017) Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 171(3):540\u201356 e25","journal-title":"Cell"},{"issue":"4","key":"4597_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun A, de Reynies A, Allory Y, Sjodahl G, Robertson AG, Seiler R et al (2020) A consensus molecular classification of muscle-invasive bladder cancer. Eur Urol 77(4):420\u2013433","journal-title":"Eur Urol"},{"issue":"6","key":"4597_CR25","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.eururo.2015.07.039","volume":"68","author":"JP Sfakianos","year":"2015","unstructured":"Sfakianos JP, Cha EK, Iyer G, Scott SN, Zabor EC, Shah RH et al (2015) Genomic characterization of upper tract urothelial carcinoma. Eur Urol 68(6):970\u2013977","journal-title":"Eur Urol"},{"issue":"4","key":"4597_CR26","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.eururo.2017.05.048","volume":"72","author":"TJ Moss","year":"2017","unstructured":"Moss TJ, Qi Y, Xi L, Peng B, Kim TB, Ezzedine NE et al (2017) Comprehensive genomic characterization of upper tract urothelial carcinoma. Eur Urol 72(4):641\u2013649","journal-title":"Eur Urol"},{"issue":"6","key":"4597_CR27","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1016\/j.juro.2016.01.006","volume":"195","author":"A Bagrodia","year":"2016","unstructured":"Bagrodia A, Cha EK, Sfakianos JP, Zabor EC, Bochner BH, Al-Ahmadie HA et al (2016) Genomic biomarkers for the prediction of stage and prognosis of upper tract urothelial carcinoma. J Urol 195(6):1684\u20131689","journal-title":"J Urol"},{"key":"4597_CR28","first-page":"S1072","volume":"79","author":"A Grahn","year":"2021","unstructured":"Grahn A, Eisfeldt J, Malm C, ForoughiAsl H, Jaremko G, Tham E et al (2021) Genomic profile\u2014a possible diagnostic and prognostic marker in upper tract urothelial carcinoma. BJU Int 79:S1072","journal-title":"BJU Int"},{"key":"4597_CR29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.euf.2018.01.005","volume":"5","author":"A Bagrodia","year":"2018","unstructured":"Bagrodia A, Audenet F, Pietzak EJ, Kim K, Murray KS, Cha EK et al (2018) Genomic profile of urothelial carcinoma of the upper tract from ureteroscopic biopsy: feasibility and validation using matched radical nephroureterectomy specimens. Eur Urol Focus. 5:365\u2013368","journal-title":"Eur Urol Focus."},{"issue":"1","key":"4597_CR30","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1038\/s41467-019-10873-y","volume":"10","author":"BD Robinson","year":"2019","unstructured":"Robinson BD, Vlachostergios PJ, Bhinder B, Liu W, Li K, Moss TJ et al (2019) Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling. Nat Commun 10(1):2977","journal-title":"Nat Commun"},{"issue":"6","key":"4597_CR31","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.ccell.2021.05.008","volume":"39","author":"Y Fujii","year":"2021","unstructured":"Fujii Y, Sato Y, Suzuki H, Kakiuchi N, Yoshizato T, Lenis AT et al (2021) Molecular classification and diagnostics of upper urinary tract urothelial carcinoma. Cancer Cell 39(6):793-809 e8","journal-title":"Cancer Cell"},{"issue":"4","key":"4597_CR32","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.eururo.2017.03.030","volume":"72","author":"R Seiler","year":"2017","unstructured":"Seiler R, Ashab HAD, Erho N, van Rhijn BWG, Winters B, Douglas J et al (2017) Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy. Eur Urol 72(4):544\u2013554","journal-title":"Eur Urol"},{"issue":"8","key":"4597_CR33","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1001\/jamaoncol.2016.1056","volume":"2","author":"D Liu","year":"2016","unstructured":"Liu D, Plimack ER, Hoffman-Censits J, Garraway LA, Bellmunt J, Van Allen E et al (2016) Clinical validation of chemotherapy response biomarker ERCC2 in muscle-invasive urothelial bladder carcinoma. JAMA Oncol 2(8):1094\u20131096","journal-title":"JAMA Oncol"},{"issue":"2","key":"4597_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41576-018-0071-5","volume":"20","author":"E Heitzer","year":"2019","unstructured":"Heitzer E, Haque IS, Roberts CES, Speicher MR (2019) Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet 20(2):71\u201388","journal-title":"Nat Rev Genet"},{"issue":"2","key":"4597_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/joim.12897","volume":"286","author":"G Barbany","year":"2019","unstructured":"Barbany G, Arthur C, Lieden A, Nordenskjold M, Rosenquist R, Tesi B et al (2019) Cell-free tumour DNA testing for early detection of cancer\u2014a potential future tool. J Intern Med 286(2):118\u2013136","journal-title":"J Intern Med"},{"issue":"6","key":"4597_CR36","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.euo.2021.04.005","volume":"4","author":"EA Green","year":"2021","unstructured":"Green EA, Li R, Albiges L, Choueiri TK, Freedman M, Pal S et al (2021) Clinical utility of cell-free and circulating tumor DNA in kidney and bladder cancer: a critical review of current literature. Eur Urol Oncol 4(6):893\u2013903","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"4597_CR37","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1111\/cas.14000","volume":"110","author":"Y Hayashi","year":"2019","unstructured":"Hayashi Y, Fujita K, Matsuzaki K, Matsushita M, Kawamura N, Koh Y et al (2019) Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma. Cancer Sci 110(5):1771\u20131779","journal-title":"Cancer Sci"},{"issue":"1","key":"4597_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001406","volume":"9","author":"C Blumendeller","year":"2021","unstructured":"Blumendeller C, Boehme J, Frick M, Schulze M, Rinckleb A, Kyzirakos C et al (2021) Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report. J Immunother Cancer. 9(1):e001406","journal-title":"J Immunother Cancer."},{"issue":"5","key":"4597_CR39","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1111\/cas.15334","volume":"113","author":"K Nakano","year":"2022","unstructured":"Nakano K, Koh Y, Yamamichi G, Yumiba S, Tomiyama E, Matsushita M et al (2022) Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma. Cancer Sci 113(5):1830\u20131842","journal-title":"Cancer Sci"},{"issue":"12","key":"4597_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2022.119359","volume":"1869","author":"LA Orofiamma","year":"2022","unstructured":"Orofiamma LA, Vural D, Antonescu CN (2022) Control of cell metabolism by the epidermal growth factor receptor. Biochim Biophys Acta Mol Cell Res 1869(12):119359","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"1","key":"4597_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.21873\/anticanres.16146","volume":"43","author":"M Hashimoto","year":"2023","unstructured":"Hashimoto M, Fujita K, Tomiyama E, Fujimoto S, Adomi S, Banno E et al (2023) Immunohistochemical analysis of HER2, EGFR, and Nectin-4 expression in upper urinary tract urothelial carcinoma. Anticancer Res 43(1):167\u2013174","journal-title":"Anticancer Res"},{"issue":"1","key":"4597_CR42","doi-asserted-by":"publisher","first-page":"16558","DOI":"10.1038\/s41598-020-72944-1","volume":"10","author":"IM Kjaer","year":"2020","unstructured":"Kjaer IM, Olsen DA, Brandslund I, Bechmann T, Jakobsen EH, Bogh SB et al (2020) Prognostic impact of serum levels of EGFR and EGFR ligands in early-stage breast cancer. Sci Rep 10(1):16558","journal-title":"Sci Rep"},{"issue":"1","key":"4597_CR43","doi-asserted-by":"publisher","first-page":"20113","DOI":"10.1038\/s41598-020-77109-8","volume":"10","author":"DA Olsen","year":"2020","unstructured":"Olsen DA, Thomsen CEB, Andersen RF, Madsen JS, Jakobsen A, Brandslund I (2020) Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations. Sci Rep 10(1):20113","journal-title":"Sci Rep"},{"issue":"10","key":"4597_CR44","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41551-017-0139-0","volume":"1","author":"N Tanaka","year":"2017","unstructured":"Tanaka N, Kanatani S, Tomer R, Sahlgren C, Kronqvist P, Kaczynska D et al (2017) Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity. Nat Biomed Eng 1(10):796\u2013806","journal-title":"Nat Biomed Eng"},{"issue":"11","key":"4597_CR45","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s00345-019-02682-1","volume":"37","author":"A Grahn","year":"2019","unstructured":"Grahn A, Tanaka N, Uhlen P, Brehmer M (2019) Volumetric imaging: a potential tool to stage upper tract urothelial carcinoma. World J Urol 37(11):2297\u20132302","journal-title":"World J Urol"},{"issue":"9","key":"4597_CR46","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41551-020-0576-z","volume":"4","author":"N Tanaka","year":"2020","unstructured":"Tanaka N, Kanatani S, Kaczynska D, Fukumoto K, Louhivuori L, Mizutani T et al (2020) Three-dimensional single-cell imaging for the analysis of RNA and protein expression in intact tumour biopsies. Nat Biomed Eng 4(9):875\u2013888","journal-title":"Nat Biomed Eng"},{"issue":"11","key":"4597_CR47","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","volume":"20","author":"D Bruni","year":"2020","unstructured":"Bruni D, Angell HK, Galon J (2020) The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer 20(11):662\u2013680","journal-title":"Nat Rev Cancer"},{"key":"4597_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb3735","author":"T Vollmer","year":"2021","unstructured":"Vollmer T, Schlickeiser S, Amini L, Schulenberg S, Wendering DJ, Banday V et al (2021) The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.abb3735","journal-title":"Sci Transl Med."},{"issue":"12","key":"4597_CR49","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1002\/cncr.25043","volume":"116","author":"BR Lane","year":"2010","unstructured":"Lane BR, Smith AK, Larson BT, Gong MC, Campbell SC, Raghavan D et al (2010) Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 116(12):2967\u20132973","journal-title":"Cancer"},{"issue":"5","key":"4597_CR50","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.molmed.2019.02.003","volume":"25","author":"RE Veerman","year":"2019","unstructured":"Veerman RE, GuclulerAkpinar G, Eldh M, Gabrielsson S (2019) Immune cell-derived extracellular vesicles\u2014functions and therapeutic applications. Trends Mol Med 25(5):382\u2013394","journal-title":"Trends Mol Med"},{"issue":"6","key":"4597_CR51","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nm.2753","volume":"18","author":"H Peinado","year":"2012","unstructured":"Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G et al (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18(6):883\u2013891","journal-title":"Nat Med"},{"issue":"1","key":"4597_CR52","doi-asserted-by":"publisher","first-page":"14749","DOI":"10.1038\/s41598-020-71573-y","volume":"10","author":"J Liu","year":"2020","unstructured":"Liu J, Wu S, Zheng X, Zheng P, Fu Y, Wu C et al (2020) Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions. Sci Rep 10(1):14749","journal-title":"Sci Rep"},{"issue":"4","key":"4597_CR53","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1071008","volume":"5","author":"B Besse","year":"2016","unstructured":"Besse B, Charrier M, Lapierre V, Dansin E, Lantz O, Planchard D et al (2016) Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. Oncoimmunology 5(4):e1071008","journal-title":"Oncoimmunology"},{"issue":"13","key":"4597_CR54","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.3390\/cancers13133242","volume":"13","author":"M Eldh","year":"2021","unstructured":"Eldh M, Mints M, Hiltbrunner S, Ladjevardi S, Alamdari F, Johansson M et al (2021) Proteomic profiling of tissue exosomes indicates continuous release of malignant exosomes in urinary bladder cancer patients, even with pathologically undetectable tumour. Cancers (Basel). 13(13):3242","journal-title":"Cancers (Basel)."},{"issue":"1","key":"4597_CR55","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1038\/s41598-020-62753-x","volume":"10","author":"S Hiltbrunner","year":"2020","unstructured":"Hiltbrunner S, Mints M, Eldh M, Rosenblatt R, Holmstrom B, Alamdari F et al (2020) Urinary exosomes from bladder cancer patients show a residual cancer phenotype despite complete pathological downstaging. Sci Rep 10(1):5960","journal-title":"Sci Rep"},{"issue":"11","key":"4597_CR56","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1007\/s00432-019-03035-6","volume":"145","author":"S Baumgart","year":"2019","unstructured":"Baumgart S, Meschkat P, Edelmann P, Heinzelmann J, Pryalukhin A, Bohle R et al (2019) MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer. J Cancer Res Clin Oncol 145(11):2725\u20132736","journal-title":"J Cancer Res Clin Oncol"},{"key":"4597_CR57","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.eururo.2020.07.003","volume":"79","author":"JJ Leow","year":"2020","unstructured":"Leow JJ, Chong YL, Chang SL, Valderrama BP, Powles T, Bellmunt J (2020) Neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma: a 2020 systematic review and meta-analysis, and future perspectives on systemic therapy. Eur Urol. 79:635\u2013654","journal-title":"Eur Urol."}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04597-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-023-04597-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04597-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T12:01:38Z","timestamp":1701518498000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-023-04597-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":57,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4597"],"URL":"https:\/\/doi.org\/10.1007\/s00345-023-04597-4","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"assertion":[{"value":"31 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Grahn: None. Eriksson: None. Gabrielsson: Scientific Advisory Board, Anjarium Biosciences and patent granted for Exosomes for targeting B-cells for therapy. Skov Madsen: None. Tham: None. Thomas: None. Uhl\u00e9n: None. Vollmer: None. Zieger: None. Osther: Consultation for Olympus, speaker for Coloplast, Boston Scientific, Olympus. Brehmer: Consultation for Boston Scientific.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a review article involving no studies on human participants and\/or animals. Informed consent is not relevant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}